目的:讨论小切口非超声乳化白内障摘除联合人工晶状体植入术在尿毒症血液透析患者的临床效果。方法:回顾性分析32例40眼有尿毒症史并行血液透析治疗的白内障患者施行小切口非超声乳化白内障摘除联合人工晶状体植入术,术后评价其疗效及并发症情况。结果:术后裸眼视力>0.3者35眼(87.5%),其中0.5～0.9者27眼,0.3～0.5者8眼;<0.3者5眼(12.5%),术中及术后各种并发症的发生率均很低。结论:小切口非超声乳化白内障摘除联合人工晶状体植入术具有术后视力恢复快、散光小、安全简便、不需要昂贵的设备等优点,是治疗尿毒症血液透析患者白内障的理想方法。

·AIM:To observe the clinical effects of the small incision non-phacoemulsification and intraocular lens(IOL)implantation for hemodialysis in uremic patient.METHODS:Forty eyes of 32 hemodialysis patients received small incision cataract non-phacoemulsification and IOL implantation,the complications and postoperative visual acuity were observed.RESULTS:Postoperatively,uncorrected visual acuity was<0.3 in 5 eyes(12.5%),>0.3 in 35 eyes(87.5%),including 0.5-0.9 in 27 eyes,0.3-0.5 in 8 eyes.The incidence of complications was very low during and after operation.CONCLUSION:After the small incision non-phaco-emulsification and IOL implantation,the visual acuity is easy to recover and the corneal astigmatism is small.The surgery is safe,convenient and economical,which is a minimally invasive treatment method for complicated cataract for hemodialysis in uremic patient.

R779.66